In the early 1990s, breakthrough discoveries on the genetics of Alzheimer’s disease led to the identification of missense mutations in the amyloid-b precursor proteingene. Research findings quickly followed, giving insights into molecular pathogenesis and possibilities for the development of new types of animal models.